Filtered By:
Vaccination: Cancer Vaccines
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 7677 results found since Jan 2013.
Breast cancer vaccines; A comprehensive and updated review
Pathol Res Pract. 2023 Aug 4;249:154735. doi: 10.1016/j.prp.2023.154735. Online ahead of print.ABSTRACTAccording to the International Agency for Research on Cancer, breast cancer is more common than lung cancer globally. By 2040, mortality from breast cancer will rise by 50% and 40%, respectively. Despite advances in chemotherapy, endocrine therapy, and HER2-targeted therapy, breast cancer metastases and recurrences remain challenging to treat. Cancer vaccines are an effective treatment option because they stimulate a long-lasting immune response that will eliminate tumor cells. In studies on the breast cancer vaccine, no ...
Source: Pathology, Research and Practice - August 23, 2023 Category: Pathology Authors: Sulieman Ibraheem Shelash Al-Hawary Ebraheem Abdu Musad Saleh Nodirjon Akhmetovich Mamajanov Nataliya S Gilmanova Hashem O Alsaab Adel Alghamdi Shakeel Ahmed Ansari Ahmed Hussien Radie Alawady Ali Hashiem Alsaalamy Ahmed Jaber Ibrahim Source Type: research
Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
CONCLUSIONThese results demonstrate that serial vaccination strategies can be effective for a subset of B cell-depleted patients.FUNDINGThe NIH (R25 NS079193, P01 AI073748, U24 AI11867, R01 AI22220, UM 1HG009390, P01 AI039671, P50 CA121974, R01 CA227473, U01CA260507, 75N93019C00065, K24 AG042489), NIH HIPC Consortium (U19 AI089992), the National Multiple Sclerosis Society (CA 1061-A-18, RG-1802-30153), the Nancy Taylor Foundation for Chronic Diseases, Erase MS, and the Claude D. Pepper Older Americans Independence Center at Yale (P30 AG21342).PMID:37606046 | DOI:10.1172/jci.insight.168102
Source: Cancer Control - August 22, 2023 Category: Cancer & Oncology Authors: Hiromitsu Asashima Dongjoo Kim Kaicheng Wang Nikhil Lele Nicholas C Buitrago-Pocasangre Rachel Lutz Isabella Cruz Khadir Raddassi William E Ruff Michael K Racke JoDell E Wilson Tara S Givens Alba Grifoni Daniela Weiskopf Alessandro Sette Steven H Kleinste Source Type: research
Outer membrane vesicle-based intranasal vaccines
Curr Opin Immunol. 2023 Aug 18;84:102376. doi: 10.1016/j.coi.2023.102376. Online ahead of print.ABSTRACTDelivery of vaccines via the mucosal route is regarded as the most effective mode of immunization to counteract infectious diseases that enter via mucosal tissues, including oral, nasal, pulmonary, intestinal, and urogenital surfaces. Mucosal vaccines not only induce local immune effector elements, such as secretory Immunoglobulin A (IgA) reaching the luminal site of the mucosa, but also systemic immunity. Moreover, mucosal vaccines may trigger immunity in distant mucosal tissues because of the homing of primed antigen-s...
Source: Current Opinion in Immunology - August 20, 2023 Category: Allergy & Immunology Authors: Peter Van der Ley Virgil Ejc Schijns Source Type: research
Perspectives on Advancing Countermeasures for Filovirus Disease: Report from a Multi-Sector Meeting
Discussion participants recommended a follow-up meeting be held in Africa with national public health and research agencies from at-risk countries to establish such a consortium.PMID:37596837 | DOI:10.1093/infdis/jiad354
Source: Cancer Control - August 19, 2023 Category: Cancer & Oncology Authors: Armand Sprecher Robert Cross Andrea Marzi Karen A Martins Daniel Wolfe Joel M Montgomery Christina F Spiropoulou Tomas Cihlar Steve Ahuka-Mundeke Tara Nyhuis Carrie Teicher Ian Crozier Jim Strong Gary Kobinger Courtney Woolsey Thomas W Geisbert Heinz Feld Source Type: research
Use of cancer vaccine after immunotherapy failure: a promising strategy for advanced NSCLC patients with secondary resistance to checkpoint inhibitors
Ann Oncol. 2023 Aug 17:S0923-7534(23)00799-8. doi: 10.1016/j.annonc.2023.08.002. Online ahead of print.NO ABSTRACTPMID:37597581 | DOI:10.1016/j.annonc.2023.08.002
Source: Ann Oncol - August 19, 2023 Category: Cancer & Oncology Authors: O Adotevi Source Type: research
